

Fundamental dimension Equity attribute | ATATLeader $31.51▼-3.28% Cap $4.35BP/E 14.7x QuantScore75/100 | CHHPeer $108.48▼-3.13% Cap $4.94BP/E 15.2x QuantScore49/100 | GHGPeer $0.9945▲+0.18% Cap $100.3MP/E 15.8x QuantScore66/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
26/100 |
88/100 |
64/100 |
Valuation Multiples, PEG & DCF upside | 98/100 | 80/100 | 64/100 |
Health Piotroski, Altman Z, leverage & liquidity | 84/100 | 24/100 | 59/100 |
Growth Revenue / earnings growth & margins | 79/100 | 28/100 | 49/100 |
Sentiment Analyst ratings, targets & revisions | 86/100 | 26/100 | 92/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 14.7x | 15.2x | 15.8x |
Forward P/E (next FY) | 2.0x | 15.5x | 0.2x |
EV / EBITDA (TTM) | 9.3x | 11.4x | 4.3x |
Price / Sales | 2.5x | 3.0x | 0.7x |
Price / Free Cash Flow | 12.7x | 22.3x | -30.2x |
PEG ratio | 0.34 | 1.75 | -0.20 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 6 / 9 | 8 / 9 |
Altman Z-Score | 6.70 (Safe) | 3.22 (Safe) | 0.53 (Distress) |
Total debt / equity | 0.38 | 14.82 | 0.93 |
Quick ratio | 1.9x | 0.9x | 1.7x |
Interest coverage | 449.4x | 4.3x | 17.2x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +35.1% | +0.8% | -18.3% |
Net income growth YoY | +27.1% | +23.5% | +51.6% |
Gross margin (TTM) | 43.2% | 45.0% | 34.7% |
Operating margin (FY) | 23.6% | 28.4% | 12.8% |
FCF margin (FY) | 18.9% | 7.8% | 1.8% |
5. Trailing price performancePrice change over period |
1M return | -2.6% | +7.4% | -2.5% |
3M return | -1.4% | -1.8% | -11.2% |
6M return | -19.2% | -8.9% | -20.4% |
Year to date | -20.0% | +13.9% | -41.2% |
1Y return | -20.8% | +11.6% | -51.3% |
3Y return | +65.7% | -4.9% | -77.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $197.68 +527.4% upside | $128.60 +18.5% upside | $-0.8367 -184.1% premium |
Wall Street consensus target | $39.70 +26.0% · range $39.70–$39.70 | $112.33 +3.5% · range $93.00–$129.00 | $5.00 +402.8% · range $5.00–$5.00 |
Consensus stance | 100% Buy0% Hold0% Sell | 11% Buy64% Hold25% Sell | 80% Buy20% Hold0% Sell |